This inventor holds 2 USPTO granted patents. Top assignee: Development Center for Biotechnology. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Chen-Hsuan Ho: Innovator in Biotechnology
Introduction
Chen-Hsuan Ho is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. With a total of 2 patents to his name, his work focuses on addressing critical medical challenges.
Latest Patents
Among his latest patents is the "Anti-human CSF-1R antibody and uses thereof." This invention involves an antibody that specifically binds to human CSF-1R, featuring a heavy chain variable domain and a light chain variable domain with specific sequences. Another notable patent is for "Quinoxaline compounds as type III receptor tyrosine kinase inhibitors." This compound is designed to inhibit kinases for the treatment of diseases mediated by such kinases, including cancers and autoimmune diseases.
Career Highlights
Chen-Hsuan Ho is affiliated with the Development Center for Biotechnology, where he continues to advance his research and innovations. His work has the potential to impact various therapeutic areas significantly.
Collaborations
He collaborates with notable colleagues, including Chu-Bin Liao and Yu-Kai Chen, who contribute to his research endeavors.
Conclusion
Chen-Hsuan Ho's innovative work in biotechnology exemplifies the impact of dedicated inventors in advancing medical science. His patents reflect a commitment to developing solutions for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile